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Objectives: To determine the prevalence and identify risk factors for iron deficiency and anemia
in pregnant Ghanaian women from urban areas. Methods: A cross-sectional study of 452 healthy
pregnant women receiving prenatal care in Accra, Ghana, was conducted. A sociodemographic
health questionnaire was performed and hematologic parameters were measured. Logistic
regression methods were used to identify risk factors for anemia and iron status. Results:
Complete data were available for 428 women. Anemia (hemoglobin b11 g/dL) was present in 144
(34%), iron deficiency (ferritin ≤16 μg/L) in 69 (16%), and iron deficiency anemia in 32 (7.5%)
women. The adjusted odds ratio (OR) for anemia was 3.4 and 9.8 if iron deficiency and malaria
parasitemia were present, respectively; the OR was 0.6 if women were at ≥36 weeks of
pregnancy. The adjusted OR for iron deficiency was 2.7 if women were at ≥36 weeks of
pregnancy and 0.12 if they had sickle trait. Conclusion: Although anemia and iron deficiency
remain substantial problems in pregnant Ghanaian women from urban areas, their prevalence is
less than previously reported.







Anemia affects over 2 billion people and the World
Health Organization (WHO) estimates that half of these4th Floor UNC Hospitals,
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007 International Federation ofcases are due to iron deficiency [1–3]. A disproportionate
percentage of anemia and iron deficiency cases occur in
low income countries [4,5], accompanied by adverse
pregnancy outcomes such as preterm birth, low birth
weight, and increased maternal mortality [6–11].
Although these adverse events exact a heavy toll in
terms of ill-health and premature death, iron deficiency
and anemia remain endemic, and global prevalence has
declined little [12–15].Gynecology and Obstetrics. Published by Elsevier Ireland Ltd.
Table 1 Health characteristics of women in the study group and stage of pregnancy a
Characteristics Study group (n=428) ≤24 weeks (n=181) ≥36 weeks (n=247) P value
Anemia 144 (34) 76 (42) 68 (28) 0.0018
Iron deficiency 69 (16) 20 (11) 49 (20) 0.015
Iron supplement during pregnancy btwice/week 113 (27) 81 (46) 32 (13) b0.0001
Malaria parasitemia 32 (7) 21 (12) 11 (4) 0.0055
Menstrual bleeding severity b NS
Little 44 (10) 20 (12) 24 (10)
Moderate 276 (66) 103 (59) 173 (70)
Heavy 101 (24) 51 (29) 50 (20)
Irregular menstruation b 274 (65) 113 (64) 161 (65) NS
Number of children NS
0–2 317 (74) 140 (79) 177 (72)
3 or more 106 (26) 37 (21) 69 (28)
Donated blood once or more 33 (8) 15 (8) 18 (7) NS
Intrauterine device 18 (6) 4 (4) 14 (6) NS
Maternal education NS
No formal education/elementary education 277 (66) 128 (73) 149 (61)
Secondary/advanced education 144 (34) 48 (27) 96 (39)
Eat meat/week btwice/week 206 (49) 86 (49) 120 (49) NS
Eat fruits/vegetables btwice/week 50 (12) 20 (11) 30 (12) NS
Take vitamin C btwice/week 389 (92) 166 (94) 223 (91) NS
No iron supplement before pregnancy 370 (88) 151 (86) 219 (89) NS
History of malaria in the past year 204 (48) 79 (45) 125 (51) NS
Folate deficiency 11 (3) 4 (2) 7 (3) NS
Sickle cell trait 56 (13) 23 (13) 33 (13) NS
a Values are given as number (percentage) unless otherwise indicated.
b Defined subjectively by the women.
63Anemia and iron deficiency in pregnant Ghanaian women from urban areasThe purpose of the present study was to determine if the
prevalence of iron deficiency and anemia in pregnant women
receiving prenatal care and living in urban areas in Ghana was
as high as suggested by previous survey data, and to identify
genetic, infectious, and sociodemographic risk factors for
iron deficiency and anemia. Such data are critical to generate
hypotheses about modifiable causes, and to select interven-
tions for future maternal or neonatal studies.
2. Materials and methods
The study was conducted in the prenatal outpatient clinics of
Korle-Bu Teaching Hospital and the Mamprobi Polyclinic, in Accra,
Ghana. These clinics care for over 350 patients each day and all
patients who attend receive free intermittent presumptive treat-
ment for malaria, and iron supplementation.
The study cohort included healthy women between 18
and 40 years of age with singleton pregnancies who received
prenatal care betweenMay and August 2003. Thosewith sickle cell
disease, major congenital or current illnesses were excluded.
Among the women eligible for the study a subset was selected by a
computer-generated random list of numbers. Recruitment, enroll-
ment, and data and specimen collection occurred during a single
outpatient visit at one of two distinct times during pregnancy: the
first prenatal visit (4–24weeks of pregnancy) and the lastmonth of
pregnancy (36–41 weeks).
Informed consent was obtained from all participants. The
Noguchi Memorial Institute for Medical Research at the University
of Ghana and theUniversity ofMichigan Ethical ReviewCommittee
approved the study.A health and sociodemographic questionnaire that included
possible risk factors for iron deficiency and anemiawas conducted.
The questionnaire was translated by an interpreter if the women
did not speak English (42%).
The following laboratory assays were performed on a venous
blood sample: a complete blood count (CBC) performed using a
Sysmex KX-21 Hematology Analyzer (Sysmex Corporation, Kobe,
Japan); erythrocyte sedimentation rate (ESR) measured using the
Sediplast system (LP Italiana Spa, Milan, Italy); and ferritin levels
using the DPC Immulite 1 ferritin assay (Diagnostic Products
Corporation, Los Angeles, USA). A sickling test using sodium
metabisulphate was conducted on all blood samples [16]. The BD
QBC fluorescence microscopy method (Becton Dickinson Co,
Franklin Lakes, NJ, USA) and a thick film (Giemsa stain) was
used for detection of malarial parasites in blood smears, while a
thin film was used for speciation. Stool samples were obtained to
investigate the presence of intestinal pathogens. The WHO
definition of anemia (hemoglobin concentration b11 g/dL) was
used [17]. Iron deficiency was defined as a serum ferritin con-
centration ≤16 μg/L [18]. Additional analyses were performed
using an alternative ferritin cutoff level of ≤12 μg/L [19,20].
Health characteristics were split into 2 groups: early
(≤24 weeks) and late (≥36 weeks) pregnancy using descriptive
tabular methods. The analyses of anemia prevalence condi-
tional on explanatory variables (e.g. iron deficiency, bleeding
severity, number of children, number of pregnancies, use of
intrauterine device, maternal education, paternal education,
number of times eating meat per week, iron supplement taken
before pregnancy and during pregnancy, having malaria in the
past year, gestation, and having sickle cell trait) relied on a
Table 2 Multivariate analysis of risk factors for anemia
using stepwise algorithm
Factor Anemia: hemoglobin




Iron deficiency (ferritin ≤16 μg/L)
Yes 69 (46) 3.4 (1.7–6.5) 0.0003
No 359 (31) 1
Sub-cohort (weeks of pregnancy)
≥36 weeks 247 (28) 0.6 (0.3–1.0) 0.044
≤24 weeks 181 (42) 1
Malaria
Positive 32 (72) 9.8 (2.6–37) 0.0007
Negative 396 (30) 1
64 C. Engmann et al.Fisher exact test procedure and logistic regression methods
with stepwise variable selection algorithms, accompanied by
95% confidence intervals. Similar methods were used in the
analyses of iron deficiency prevalence. Statistical analyses
were performed only on subjects with complete data available.
Data analyses were performed using SAS system software
version 9.1.3 (SAS Institute, Cary, NC, USA).
3. Results
A total of 452 pregnant womenwere enrolled in the study and
24 (5%) were excluded after enrollment due to incomplete
data, leaving 428women. A total of 181womenwere enrolled
at 24 weeks of pregnancy or earlier (22% in the first and 78% in
the second trimester), while 247were enrolled during the last
month of pregnancy.
Table 1 describes the prevalence of anemia and iron
deficiency for the entire cohort and separately for women
enrolled in early and late pregnancy. Also listed are factors
that may predict these outcomes. The prevalence of these
factors are listed separately for each group (≤24 weeks
versus ≥36 weeks) to identify any heterogeneity between
groups that may have influenced the prevalence of anemia
or iron deficiency, independent of the effect of length of
pregnancy. All factors were similar between groups except
malaria parasitemia and iron supplementation during preg-
nancy. Parasitemia was less common in late pregnancy while
iron supplementation was more common in late pregnancy,
presumably as a result ofmedical therapies during pregnancy.
Themean hemoglobin (Hb) for the entire cohort was 11.3±
1.3 g/dL (range, 6.1–15.5). Anemia (Hbb11 g/dL) was
present in 144 (34%) women. Thirteen women (3%) had Hb
levels b9 g/dL but ≥7 g/dL, while 4 women had Hb levels
b7 g/dL.Women at≤24weeks of pregnancy had amean Hb ofTable 3 Multivariate analysis of risk factors for iron deficiency u
Factor Iron deficiency: ferritin lev
Sub-cohort (gestational weeks)
≥36 weeks 247 (20)
≤24 weeks 181 (11)
Sickle status
Trait 56 (5)
Negative 371 (18)10.9±1.4 g/dL (range, 6.1–15.5); women in the last month
of pregnancy had a mean Hb of 11.6±1.1 g/dL (range, 8.1–
14.2). Of 144 anemic women, 32 (22%) had ferritin≤16 μg/L,
23 had malaria, and 19 had sickle cell trait. In multivariate
analysis of risk factors for anemia, the odds of being anemic
were increased if women were iron deficient or had malaria
parasitemia. These odds of anemia were almost halved if
women were at ≥36 weeks of pregnancy (Table 2).
The median serum ferritin level for the entire cohort was
34.7 μg/L (interquartile range [IQR], 20–54 μg/L). Sixty-nine
women (16%) had ferritin levels ≤16 μg/L, and 32 (46%) of
these were anemic; 45 women (11%) had ferritin levels
≤12 μg/L. The median serum ferritin levels in women with
malaria parasitemia was 91 μg/L (IQR, 33–157 μg/L). Among
women without malaria parasitemia, the median ferritin
level was 33 μg/L (IQR, 20–50 μg/L). Among women with
sickle cell trait (n=56), the median ferritin level was 42 μg/L
(IQR, 28–65 μg/L). Women without sickle cell trait had me-
dian ferritin values of 33 μg/L (IQR, 20–51 μg/L). In multi-
variate analysis of risk factors for iron deficiency, the odds of
having a low ferritin level were increased if women were
in their last month of pregnancy, and decreased if they had
sickle trait (Table 3).
A total of 32 women (7%) had malarial parasitemia. Among
parasitemic women, 23 (72%) were anemic and 2 (6%) were
iron deficient. Malaria parasitemia was significantly less
common in the last month of pregnancy compared with at
≤24 weeks of pregnancy (Table 1). In 220 stool specimens
examined under microscopy, 3 had Entamoeba coli cysts and
1 had Entamoeba histolytica cysts.
4. Discussion
The present study reports a comparatively low prevalence of
anemia, iron deficiency, and iron deficiency anemia (34%,
16%, and 7.5%, respectively) in pregnant Ghanaian women.
Lassey et al. [21] reported that 56% of pregnant Ghanaian
women in urban areas had hemoglobin levels below 11 g/dL,
while the 2003 Demographic and Health Survey (DHS)
reported anemia prevalence in 400 pregnant women aged
15–49 years as 65% [22]. Mockenhaupt et al. [19] reported
prevalence of anemia and iron deficiency of 54% and 46%,
respectively, in a study of 540 pregnant Ghanaian women
from rural areas. A possible explanation for the lower prev-
alence of anemia and iron deficiency in the present study
compared with other studies may be that women in our study
population are primarily coastal urban dwellers residing in an
area with increased media exposure, which may promote
improved health practices. In support of this hypothesis is the
DHS survey in which urban women were 6 times more likelysing stepwise algorithm





65Anemia and iron deficiency in pregnant Ghanaian women from urban areasthan rural Ghanaian women to read a newspaper, watch TV, or
listen to the radio.
There was a lower prevalence of malaria parasitemia and
anemia, but a higher incidence of iron deficiency late in
pregnancy. The availability of free intermittent presumptive
treatment or the seasonal variations in malaria prevalence
may explain the reduced incidence of malaria parasitemia
and anemia late in pregnancy. In contrast, the adjusted odds
ratio of being iron deficient significantly increased during the
last month of pregnancy compared with the first prenatal
visit. This was despite the fact that nearly 90% of women in
their third trimester reported taking iron twice or more
weekly, compared with only 50% of women at ≤24 weeks of
pregnancy. There are several possible explanations for this
paradox. The reporting may have been inaccurate, the pre-
scribed doses inadequate, or routine iron supplementation
during pregnancy may be unsuccessful in preventing iron
deficiency [6,7,11]. Assessing these possibilities is critical in
developing strategies for the prevention of iron deficiency in
pregnancy.
An intriguing finding of the present study was that
pregnant women with sickle cell trait present a decreased
risk of having iron deficiency. While there is an established
association between sickle cell disease and iron deficiency,
there are few data on sickle cell trait and iron deficiency in
pregnancy [23,24]. Hershko et al. [25] observed a reciprocal
relationship between sickle cell trait and iron deficiency
anemia in 75 Lebanese subjects. They postulated that in-
creased iron absorption, or reduced iron requirements in
these patients resulted in less risk of discrepancy between
iron supply and demand. Further research is needed to
determine whether sickle cell trait confers increased pro-
tection against iron deficiency.
There are a number of limitations to the present study. We
did not investigate the presence of HIV/AIDS and homozygous
alpha thalassemia, both of which are associated with anemia
and iron deficiency. However, it is unlikely that HIV/AIDS in-
fluenced the outcome of this study because of the low
prevalence of HIV in Ghana (2.7% of Ghanaianwomen between
15 and 49 years of age [22]). The prevalence of homozygous
alpha thalassemia in this population is also low (3.7% [19]), and
all enrolled women denied any major illness. Additionally, the
cross-sectional study design limits the ability to draw infer-
ences about the effect of length of pregnancy on outcomes. To
minimize this problem, we compared the cohorts enrolled
early in pregnancy with those enrolled in the last month, with
respect to factors that might influence the prevalence of iron
deficiency and anemia. All factors were similar between
groups except for those plausibly influenced by pregnancy-
related care (administration of malaria intermittent presump-
tive treatment and iron supplementation). Finally, partici-
pants in this study had low-risk pregnancies and were healthy,
thus it may not be possible to generalize these results across
the whole population.
Although anemia and iron deficiency remain substantial
problems, the data are encouraging because the prevalence of
these disorders is considerably less than previously reported.
The lower prevalence of malaria parasitemia among women in
the last month of pregnancy also suggests a benefit of medical
intervention with intermittent presumptive treatment. There
was an inverse relationship between sickle cell trait and iron
deficiency, and we speculate that sickle cell trait may confer aprotective benefit against the occurrence of iron deficiency.
Increased research and programmatic emphasis should be
placed on decreasing modifiable risk factors for anemia, iron
deficiency, and malaria parasitemia, such as improved nutri-
tional intake of iron-rich local foods, wider use of insecticide-
impregnated bed nets and the expanded use of intermittent
presumptive treatment in the prenatal period. The potential
benefits of preconception compared to intra-pregnancy iron
supplementation should be investigated, as well as strategies
for improving compliance with preventive therapies.
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